|
Volumn 43, Issue 16, 2000, Pages 3111-3117
|
Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIPHENYLSULFONAMIDE DERIVATIVE;
BMS 193884;
ENDOTHELIN A RECEPTOR ANTAGONIST;
N (3,4 DIMETHYL 5 ISOXAZOLYL) 4' (2 OXAZOLYL)[1,1' BIPHENYL] 2 SULFONAMIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONGESTIVE HEART FAILURE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG POTENCY;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
IN VITRO STUDY;
IN VIVO STUDY;
NONHUMAN;
RABBIT;
RAT;
STRUCTURE ACTIVITY RELATION;
ADMINISTRATION, ORAL;
ANIMALS;
BIOLOGICAL AVAILABILITY;
BLOOD PRESSURE;
CAROTID ARTERIES;
DRUG EVALUATION, PRECLINICAL;
HYPERTENSION;
INJECTIONS, INTRAVENOUS;
MACACA FASCICULARIS;
MUSCLE CONTRACTION;
MUSCLE, SMOOTH, VASCULAR;
OXAZOLES;
RABBITS;
RADIOLIGAND ASSAY;
RATS;
RECEPTOR, ENDOTHELIN A;
RECEPTORS, ENDOTHELIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONAMIDES;
|
EID: 0034632777
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm000105c Document Type: Article |
Times cited : (37)
|
References (30)
|